At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the drug's main patent today, bringing patients hefty savings.

At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the drug's main patent Wednesday, bringing patients hefty savings.

Fosamax, one in a class of drugs called bisphosphonates, is supposed to make bones stronger. But now there's mounting evidence that for some women, taking Fosamax or its generic alendronate for ...

Watson Pharmaceuticals Inc. will begin shipping generic versions of Merck & Co.’s osteoporosis drug Fosamax. Merck will make and supply the drug and receive a share of the profit in the U.S ...

Fosamax generic cost — without a prescription online. Maybe, for instance, you heard that it doesn't build quality bone, that there is a risk of jaw demineralization, and that it's more harmful to ...

WHITEHOUSE STATION, N.J. Merck has signed a deal for an authorized generic form of its osteoporosis drug Fosamax, to become available after the patents of the drug expires on Feb. 6, according to ...

This is the generic version of the osteoporosis drug Fosamax by Merck. The drug will be available in 5 mg, 10 mg, 35 mg, 40 mg and 70 mg strengths.

Popular osteoporosis drugs may have opposite effect in some, experts say. March 8, 2010— -- Sandy Potter, 59, of Queens, N.Y., was jumping rope with neighborhood children when she felt her ...

DEAR DR. ROACH: I’m a 65-year-old, overweight white woman. I recently had a DEXA scan, and based on the results, my general physician prescribed Fosamax for osteopenia. The first dose created a ...

Drug researcher Merck & Co (NYSE:MRK) has sued Teva Pharmaceuticals (Nasdaq:TEVA) to block its proposed sale of a generic version of Merck's anti-osteoporosis drug Fosamax. In papers filed late on ...

As Merck & Co. was hit with big punitive damages in a Vioxx case yesterday, plaintiffs' attorneys are setting their sights on one of the company's other blockbusters: osteoporosis drug Fosamax ...